Advanced Life Settlement
Portfolio 2014-4, LLC
ALSP 2014-4, LLC
Table of Contents
BDO Agreed Upon Procedures 3-6
ALSP 2014-4 Fund Summary 7
Policy Status Report – 21st Services 8
Hewett, Policy 1269 9-17
Life Expectancy - 21st & AVS
Proof of Ownership – TransAmerica
Greenberg, Policy 1260 18-26
Life Expectancy - 21st & AVS
Proof of Ownership – Phoenix
Mullinix, Policy 1272 27-37
Life Expectancy - 21st & AVS
Proof of Ownership – TransAmerica
Wolfson, Policy 1271 38-47
Life Expectancy - 21st & AVS
Proof of Ownership – American National
Cerullo, Policy 1273 48-57
Life Expectancy - 21st & LSI (Longevity Services, Inc.)
Proof of Ownership – Allianz
Palacci, Policy 1258 58-63
Life Expectancy - 21st
Proof of Ownership – Ameritas
All information provided in this book is for internal use only. The information included is confidential, proprietary
and not meant for public dissemination. Some of the information in this book has been redacted in order to maintain
the privacy of the insureds.
3
CONFIDENTIAL, NOT TO BE DUPLICATED
4
CONFIDENTIAL, NOT TO BE DUPLICATED
5
CONFIDENTIAL, NOT TO DUPLICATED
6
CONFIDENTIAL, NOT TO BE DUPLICATED
ALSP 2014-4 Fund Summary
Insured Last Name Policy ID: Face Acquisition Gender: Insurance Current Average ROI Premium Months
1258 Amount: Cost: Rating: Age*: LE: at LE: & Servicing Escrowed:
Palacci Escrowed:
Greenberg $3,500,000.00 $1,700,863.53 Female A+ 85.1 92 6.77 48
$527,134.00 36
Hewett 60
Wolfson 1260 $2,000,000.00 $1,193,075.29 Male B+ 85.3 47 14.04 $446,755.00 72
Mullinix 36
Cerullo 1269 $10,000,000.00 $6,818,355.29 Male A+ 82.3 59 9.50 $1,896,002.00 60
1271 $7,000,000.00 $3,499,101.18 Male A 83.8 64 14.01 $221,636.00
1272 $2,500,000.00 $1,923,764.71 Male A+ 89.5 30 11.05 $2,600.00
1273 $8,500,000.00 $5,990,161.58 Female A 85.3 72 5.90 $2,061,875.00
Total Face Amount: $33,500,000.00
$21,125,321.58
Total Acquisition Costs:
47.67%
Average Acquisition Cost
(Excluding Premium & $5,156,002.00
85.2
Servicing):
Total Premium & Servicing
Escrowed:
Average Age:
Average LE: 60.7
Weighted ROI: 9.19%
*Current age calculated as of March 31st, 2016
The above projections are for demonstrative purposes only. Projections and actual returns of ALSP 2014-4 and future funds will vary depending on the performance of the policies in each specific fund.
CONFIDENTIAL, NOT TO BE DUPLICATED
7
Policy Status ASR Alternative Investments, LP
Generation Date: 21-Mar-2016
Policy Standing Count Face
Good
Grace 8 $48,500,000
Total
0 $0
8 $48,500,000
21st Policy ID Policy Number Insured Name Carrier Face Amount Effective Date Standing
15973 Klein American National Insurance Company $5,000,000.00 15-Jul-2008 Good
16974 Good
15208 Wolfson American National Insurance Company $7,000,000.00 19-Mar-2007 Good
16964 Good
13704 Rosenberg Lincoln National Life Insurance Company $10,000,000.00 21-Nov-2007 Good
17059 Good
13733 Mullinix Transamerica Life Insurance Company $2,500,000.00 03-Aug-1990 Good
15948 Good
Greenberg PHL Variable Insurance Company $2,000,000.00 08-Nov-2007
Cerullo $8,500,000.00 28-Dec-2010
Palacci Allianz Life Insurance Company of North $3,500,000.00 04-May-2009
America
Union Central Life Insurance Company
Hewett Transamerica Life Insurance Company $10,000,000.00 17-Jan-2003
CONFIDENTIAL, NOT TO BE DUPLICATED
8
Policy ROI Illustration Hewett
Date Calculator Prepared: Months Underwriter 4/1/2015
Policy ID: 50 21 ST ALSP2014-1269
68 AVS
LE 1 Multiplier
LE 2
LE 3 7.25
190
Full Policy Details
Insurance Company: TransAmerica
Company Rating: A+
Type of Death Benefit:
Face Amount (Death Benefit): FDB
Leveled or Optimized Annual Premium Expense: $10,000,000
Annual Premium Expense (Year 1):
DOB of Insured: Optimized
Age as of Date Prepared: $88,836
Gender:
Longest LE (In Months): 1934
Average LE (In Months): 81.3
Male
68
59
Purchase Details
Years Escrowed For Premiums (Estimated): 5
Premiums Paid Through Date: 4/1/2020
Acquisition Cost: $6,818,355
Acquisition Cost as a Percentage of Face Amount: 68.18%
Estimated Return Including Premium Refunds/Calls
Cost (Includes Amount Paid
Upon Maturity
Year Year Insured Age Escrow (Includes Escrow Gain/ Loss Yearly IRR
1 Reserve) Reserve) 94.67%
2 36.03%
3 2016 82.3 $ (6,818,355) $ 11,613,463 $ 4,795,108 20.54%
4 13.39%
5 2017 83.3 $ (6,818,355) $ 11,247,542 $ 4,429,187 9.22%
6 6.45%
7 2018 84.3 $ (6,818,355) $ 10,856,636 $ 4,038,281 4.44%
8 2.91%
9 2019 85.3 $ (6,818,355) $ 10,443,469 $ 3,625,114 1.68%
10 0.64%
2020 86.3 $ (6,818,355) $ 10,000,000 $ 3,181,645 9.50%
2021 87.3 $ (7,294,430) $ 10,000,000 $ 2,705,570
2022 88.3 $ (7,805,299) $ 10,000,000 $ 2,194,701
2023 89.3 $ (8,348,425) $ 10,000,000 $ 1,651,575
2024 90.3 $ (8,922,459) $ 10,000,000 $ 1,077,541
2025 91.3 $ (9,544,382) $ 10,000,000 $ 455,618
LE (in Months) 59
The above chart is for illustrative purposes only. It should be used as a reference and no specific Return On Investment (“ROI”) is guaranteed or
implied. All calculations rely on assumptions about future circumstances. Actual returns may vary if the relied upon circumstances are not accurate.
Confidential Medical Summary
The Insured is an 81.3 year old male with a history of stage II prostate cancer. In 2005 he was diagnosed
with Coronary artery disease and has had bypass grafting and /or angioplasties/stents in the last ten
years. He has hypertension, diabetes and suffers from mild depression and anxiety. A 2015 study shows
significant stenosis of the internal and external carotid arteries. He has a BMI of 22.2, current use of
tobacco includes pipes and cigars. He functions with weakness and fatigue. Current medications include;
Vicodin, Xanax, Zocor and Ambien.
9 CONFIDENTIAL, NOT TO BE DUPLICATED
10 CONFIDENTIAL, NOT TO BE DUPLICATED
11 CONFIDENTIAL, NOT TO BE DUPLICATED
12 CONFIDENTIAL, NOT TO BE DUPLICATED
13 CONFIDENTIAL, NOT TO BE DUPLICATED
14 CONFIDENTIAL, NOT TO BE DUPLICATED
15 CONFIDENTIAL, NOT TO BE DUPLICATED
CONFIDENTIAL, NOT TO BE DUPLICATED
16
CONFIDENTIAL, NOT TO BE DUPLICATED
17
Policy ROI Illustration Greenberg
Date Calculator Prepared: Months Underwriter 11/17/2014
Policy ID: 42 21 ST ALSP2014-1260
52 AVS
LE 1 Multiplier
LE 2
LE 3 12.23
295
Full Policy Details
Insurance Company: PHL Variable
Company Rating: B+
Type of Death Benefit:
Face Amount (Death Benefit): FDB
Leveled or Optimized Annual Premium Expense: $2,000,000
Annual Premium Expense (Year 1): Optimized
DOB of Insured: $123,846
Age as of Date Prepared:
Gender: 1931
Longest LE (In Months): 83.9
Average LE (In Months): Male
52
47
Purchase Details
Years Escrowed For Premiums (Estimated): 3
Premiums Paid Through Date: 11/17/2017
Acquisition Cost: $1,193,075
Acquisition Cost as a Percentage of Face Amount:
59.65%
Estimated Return Including Premium Refunds/Calls
Year Year Insured Cost (Includes Amount Paid Gain/ Loss Yearly IRR
Age Escrow Reserve) Upon Maturity
1 (Includes Escrow $ 1,125,034 139.00%
2 2015 84.9 $ (1,193,075) $ 930,561 43.43%
3 2016 85.9 $ (1,193,075) Reserve) $ 806,925 22.66%
4 2017 86.9 $ (1,193,075) $ 2,318,109 $ 674,718 13.48%
5 2018 87.9 $ (1,325,282) $ 2,123,636 $ 546,044 8.43%
6 $ 2,000,000 $ 422,106 5.29%
7 2019 88.9 $ (1,453,956) $ 2,000,000 $ 287,428 3.03%
8 2020 89.9 $ (1,577,894) $ 108,193 0.99%
2021 90.9 $ (1,712,572) $ 2,000,000 14.04%
2022 91.9 $ (1,891,807) $ 2,000,000
$ 2,000,000
LE (in Months) $ 2,000,000
47
The above chart is for illustrative purposes only. It should be used as a reference and no specific Return On Investment (“ROI”) is guaranteed or
implied. All calculations rely on assumptions about future circumstances. Actual returns may vary if the relied upon circumstances are not accurate.
Confidential Medical Summary
The insured is a 83.6 year old male with stage III Lymphoma, Diabetes, Hypertension and degenerative vascular
disease. He has Diverticulosis, mild renal insuffiencies and a history of kidney stones. He suffers from age
related ocular issues including, cataracts, glaucoma, macular degeneration and retina tear. He has had multiple
surgeries of the spine and continues to suffer from Osteoarthritis, Significant spinal disc desease, Stenosis and
Sciatica. Former smoker and currently maintains responsible alcohol use. His body mass index(BMI) is 34.3.
CONFIDENTIAL, NOT TO BE DUPLICATED
18
CONFIDENTIAL, NOT TO BE DUPLICATED
19
20 CONFIDENTIAL, NOT TO BE DUPLICATED
21 CONFIDENTIAL, NOT TO BE DUPLICATED
CONFIDENTIAL, NOT TO BE DUPLICATED
22
CONFIDENTIAL, NOT TO BE DUPLICATED
23
CONFIDENTIAL, NOT TO BE DUPLICATED
24
25 CONFIDENTIAL, NOT TO BE DUPLICATED
26 CONFIDENTIAL, NOT TO BE DUPLICATED
Policy ROI Illustration Mullinix
Date Calculator Prepared: Months Underwriter 10/14/2015
Policy ID: 29 21 ST ALSP2014-1272
30 AVS
LE 1 Multiplier
LE 2
LE 3 21.82
305
Full Policy Details
Insurance Company: TransAmerica
Company Rating: A+
Type of Death Benefit:
Face Amount (Death Benefit): FDB
Leveled or Optimized Annual Premium Expense: $2,500,000
Annual Premium Expense (Year 1): Optimized
DOB of Insured:
Age as of Date Prepared: $0
Gender: 1926
Longest LE (In Months):
Average LE (In Months): 89.0
Male
30
30
Purchase Details
Years Escrowed For Premiums (Estimated): 0
Premiums Paid Through Date: 10/14/2015
Acquisition Cost: $1,923,765
Acquisition Cost as a Percentage of Face Amount:
76.95%
Estimated Return Including Premium Refunds/Calls
Amount Paid
Year Year Insured Cost (Includes Upon Maturity Gain/ Loss Yearly IRR
Age Escrow Reserve) (Includes Escrow
1 $ 576,235 29.95%
2 Reserve) $ 576,235 14.00%
3 $ 576,235 9.13%
4 2016 90.0 $ (1,923,765) $ 2,500,000 $ 520,295 6.15%
5 $ 320,814 3.08%
6 2017 91.0 $ (1,923,765) $ 2,500,000 $ 106,303 0.86%
11.05%
2018 92.0 $ (1,923,765) $ 2,500,000
2019 93.0 $ (1,979,705) $ 2,500,000
2020 94.0 $ (2,179,186) $ 2,500,000
2021 95.0 $ (2,393,697) $ 2,500,000
LE (in Months) 30
The above chart is for illustrative purposes only. It should be used as a reference and no specific Return On Investment (“ROI”) is guaranteed or
implied. All calculations rely on assumptions about future circumstances. Actual returns may vary if the relied upon circumstances are not accurate.
Confidential Medical Summary
The Insured is a 89 year old male with an average life expectancy of 30 months. His primary impairment is
Chronic Lymphocytic Leukemia. He has had multiple surgeries which include, coronary PCI with multiple
stents. He has stage II malignant melanoma with multiple skin cancer excisions. He stopped smoking in 1980
and continues to use alcohol responsibly. He also has a history with bleeding ulcers. In 2012 he was he
received six months of chemotherapy and in 2013 he received radiation therapy. Doctors notes indicate that
he has a frail appearance with a BMX (body mass index) of 24.6. Medications include; ASA, Doxycycline,
Lasix, Levothyroxine and Pravastatin.
27 CONFIDENTIAL, NOT TO BE DUPLICATED
28 CONFIDENTIAL, NOT TO BE DUPLICATED
29 CONFIDENTIAL, NOT TO BE DUPLICATED
30 CONFIDENTIAL, NOT TO BE DUPLICATED
CONFIDENTIAL, NOT TO BE DUPLICATED
31
CONFIDENTIAL, NOT TO BE DUPLICATED
32
33 CONFIDENTIAL, NOT TO BE DUPLICATED
CONFIDENTIAL, NOT TO BE DUPLICATED
34
CONFIDENTIAL, NOT TO BE DUPLICATED
35
CONFIDENTIAL, NOT TO BE DUPLICATED
36
CONFIDENTIAL, NOT TO BE DUPLICATED
37
Policy ROI Illustration Wolfson
Date Calculator Prepared: 10/14/2015
ALSP2014-1271
Policy ID:
Multiplier
Months Underwriter
21 ST 10.16
LE 1 52 AVS 190
LE 2 75
LE 3
Full Policy Details
Insurance Company: Anico
Company Rating: A
Type of Death Benefit:
Face Amount (Death Benefit): FDB
Leveled or Optimized Annual Premium Expense: $7,000,000
Annual Premium Expense (Year 1): Optimized
DOB of Insured: $143,824
Age as of Date Prepared:
Gender: 1932
Longest LE (In Months): 83.3
Average LE (In Months): Male
75
64
Purchase Details
Years Escrowed For Premiums (Estimated): 6
Premiums Paid Through Date: 10/14/2021
Acquisition Cost: $3,499,101
Acquisition Cost as a Percentage of Face Amount:
49.99%
Estimated Return Including Premium Refunds/Calls
Amount Paid
Year Year Insured Cost (Includes Upon Maturity Gain/ Loss Yearly IRR
Age Escrow Reserve) (Includes Escrow
1 106.56%
2 Reserve) 42.45%
3 26.43%
4 2016 84.3 $ (3,499,101) $ 7,071,912 $ 3,572,811 19.16%
5 15.02%
6 2017 85.3 $ (3,499,101) $ 7,000,000 $ 3,500,899 12.35%
7 9.53%
8 2018 86.3 $ (3,499,101) $ 7,000,000 $ 3,500,899 6.27%
9 3.18%
10 2019 87.3 $ (3,499,101) $ 7,000,000 $ 3,500,899 0.20%
14.01%
2020 88.3 $ (3,499,101) $ 7,000,000 $ 3,500,899
2021 89.3 $ (3,499,101) $ 7,000,000 $ 3,500,899
2022 90.3 $ (3,890,233) $ 7,000,000 $ 3,109,767
2023 91.3 $ (4,756,180) $ 7,000,000 $ 2,243,820
2024 92.3 $ (5,775,820) $ 7,000,000 $ 1,224,180
2025 93.3 $ (6,917,359) $ 7,000,000 $ 82,641
LE (in Months) 64
The above chart is for illustrative purposes only. It should be used as a reference and no specific Return On Investment (“ROI”) is guaranteed or implied. All
calculations rely on assumptions about future circumstances. Actual returns may vary if the relied upon circumstances are not accurate.
Confidential Medical Summary
The insured is a 83.3 year old male with an average life expectancy of 64 months. He has a history of coronary artery
disease. He had a pulmonary embolism and stents implanted in 2014. The insured has had multiple falls in the past 5
years and sufferes from recurring dizziness from vertigo. He has a history of smoking and alcohol misuse. In
December he was noted for increased shortness of breath. His BMX (body mass index) is 26.5 and medications
include; Candesartan, Pantoprazole, Hydromorphone and Coumadin.
CONFIDENTIAL, NOT TO BE DUPLICATED
38
CONFIDENTIAL, NOT TO BE DUPLICATED
39
CONFIDENTIAL, NOT TO BE DUPLICATED
40
CONFIDENTIAL, NOT TO BE DUPLICATED
41
CONFIDENTIAL, NOT TO BE DUPLICATED
42
CONFIDENTIAL, NOT TO BE DUPLICATED
43
CONFIDENTIAL, NOT TO BE DUPLICATED
44
CONFIDENTIAL, NOT TO BE DUPLICATED
45
CONFIDENTIAL, NOT TO BE DUPLICATED
46
47 CONFIDENTIAL, NOT TO BE DUPLICATED
Policy ROI Illustration Cerullo
Date Calculator Prepared: Months Underwriter 1/22/2016
Policy ID: 76 AVS ALSP2014-1273
67 LSI
LE 1 Multiplier
LE 2
LE 3 185
275
Full Policy Details
Insurance Company: Allianz
Company Rating: A
Type of Death Benefit:
Face Amount (Death Benefit): FDB
Leveled or Optimized Annual Premium Expense: $8,500,000
Annual Premium Expense (Year 1): Optimized
DOB of Insured: $410,975
Age as of Date Prepared:
Gender: 1931
Longest LE (In Months): 85.1
Average LE (In Months): Female
76
72
Purchase Details
Years Escrowed For Premiums (Estimated): 5
Premiums Paid Through Date: 1/22/2021
Acquisition Cost: $5,990,161
Acquisition Cost as a Percentage of Face Amount:
70.47%
Estimated Return Including Premium Refunds/Calls
Amount Paid
Year Year Insured Cost (Includes Upon Maturity Gain/ Loss Yearly IRR
Age Escrow Reserve) (Includes Escrow
1 100.47%
2 Reserve) 36.61%
3 20.24%
4 2017 86.1 $ (5,990,161) $ 10,143,900 $ 4,153,739 12.82%
5 8.61%
6 2018 87.1 $ (5,990,161) $ 9,732,925 $ 3,742,764 5.90%
7 3.85%
8 2019 88.1 $ (5,990,161) $ 9,321,950 $ 3,331,789 1.72%
5.90%
2020 89.1 $ (5,990,161) $ 8,910,975 $ 2,920,814
2021 90.1 $ (5,990,161) $ 8,500,000 $ 2,509,839
2022 91.1 $ (6,401,136) $ 8,500,000 $ 2,098,864
2023 92.1 $ (6,884,892) $ 8,500,000 $ 1,615,108
2024 93.1 $ (7,682,892) $ 8,500,000 $ 817,108
LE (in Months) 72
The above chart is for illustrative purposes only. It should be used as a reference and no specific Return On Investment (“ROI”) is guaranteed or
implied. All calculations rely on assumptions about future circumstances. Actual returns may vary if the relied upon circumstances are not
accurate.
Confidential Medical Summary
The insured is an 85 year old female with Coronary Artery Disease, obstructive cardiomyopathy and
rheumatoid arthritis. Surgical history includes various excisions of Basal Cell Carcinoma (BCC) and
the insertion of a pacemaker. Medications include Alendronate, Diltiazem, Hydrocodone-
Acetaminophen, Labetalol and Methotrexate.
CONFIDENTIAL, NOT TO BE DUPLICATED
48
CONFIDENTIAL, NOT TO BE DUPLICATED
49